$265.12−2.21%Close 13 Nov 2026 · Market value $43.51B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
IQVIA is valued at $43.51B on its latest close. Its price is 31.2 times its earnings.
| Market value | $43.51B |
|---|
| Enterprise value | $57.71B |
|---|
| Price / earnings | 31.21 |
|---|
| Price / sales | 2.51 |
|---|
| Price / book | 6.53 |
|---|
| EV / EBITDA | 16.79 |
|---|
| EV / sales | 3.33 |
|---|
| Price / free cash flow | 20.93 |
|---|
| Price / free cash flow, own 5-year average | 21.00 |
|---|
| EV / EBIT | 25.87 |
|---|
| EV / free cash flow | 27.61 |
|---|
| Free cash flow yield | 4.8% |
|---|
Share price
| Latest close | $265.12 |
|---|
| Day's change | −2.2% |
|---|
| 52-week high | $284.50 |
|---|
| 52-week low | $154.50 |
|---|
| From 52-week high | −6.8% |
|---|
| Return · 1 month | −0.7% |
|---|
| Return · 3 months | +3.5% |
|---|
| Return · year to date | +17.6% |
|---|
| Return · 1 year | +20.0% |
|---|
| Beta · 1 year against the S&P 500 | 0.68 |
|---|
| 50-day average | $267.41 |
|---|
| 200-day average | $211.03 |
|---|
| RSI 14 | 46.5 |
|---|
| Average volume · 20 sessions | 1.5M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 13.4% |
|---|
| Net margin | 8.3% |
|---|
| Free cash flow margin | 12.6% |
|---|
| Return on equity | 21.6% |
|---|
| Return on assets | 6.5% |
|---|
| Return on invested capital | 7.7% |
|---|
| Return on invested capital, 5-year average | 7.5% |
|---|
| Return on capital employed | 10.5% |
|---|
| Stock-based compensation / revenue | 1.5% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $1.98B |
|---|
| Total debt | $16.04B |
|---|
| Net debt | $13.90B |
|---|
| Current ratio | 0.75 |
|---|
| Quick ratio | 0.31 |
|---|
| Debt / equity | 2.47 |
|---|
| Net debt / EBITDA | 4.18 |
|---|
| Interest coverage | 2.99 |
|---|
Growth
| Revenue, latest quarter on a year | +8.0% |
|---|
| Revenue, twelve months on a year | +8.8% |
|---|
| EPS, latest quarter on a year | +8.8% |
|---|
| EPS, twelve months on a year | +13.0% |
|---|
| Revenue, 5-year compound | +7.5% |
|---|
| Revenue, 10-year compound | +11.0% |
|---|
| Net income, 5-year compound | +37.3% |
|---|
| Free cash flow, 5-year compound | +8.8% |
|---|
| EPS, 5-year compound | +40.5% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 174M |
|---|
| Shares outstanding, 5-year compound | −2.3% |
|---|
| Net share repurchases | $1.24B |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $252.0M |
|---|
| Effective tax rate | 15.8% |
|---|
IQV in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.